Filing Details
- Accession Number:
- 0000950142-15-000894
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-27 18:33:46
- Reporting Period:
- 2015-04-23
- Filing Date:
- 2015-04-27
- Accepted Time:
- 2015-04-27 18:33:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434868 | Esperion Therapeutics Inc. | ESPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1172252 | N Andrew Schiff | 888 7Th Avenue 30Th Floor New York NY 10106 | No | No | Yes | No | |
| 1250195 | Steve Elms | 888 7Th Avenue, 30Th Floor New York NY 10106 | No | No | Yes | No | |
| 1297291 | J Dennis Purcell | 888 7Th Avenue, 30Th Floor New York NY 10106 | No | No | Yes | No | |
| 1350778 | Aisling Capital Ii Lp | 888 7Th Avenue 30Th Floor New York NY 10106 | No | No | Yes | No | |
| 1376171 | Aisling Capital Partners Llc | 888 7Th Avenue, 30Th Floor New York NY 10106 | No | No | Yes | No | |
| 1376172 | Aisling Capital Partners, Lp | 888 7Th Avenue, 30Th Floor New York NY 10106 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-04-23 | 150,000 | $109.10 | 1,904,594 | No | 4 | S | Indirect | By Aisling Capital II, L.P. |
| Common Stock | Disposition | 2015-04-24 | 5,743 | $108.00 | 1,898,851 | No | 5 | S | Indirect | By Aisling Capital II, LP |
| Common Stock | Disposition | 2015-04-24 | 61,726 | $106.10 | 1,837,125 | No | 5 | S | Indirect | By Aisling Capital II, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Aisling Capital II, L.P. |
| No | 5 | S | Indirect | By Aisling Capital II, LP |
| No | 5 | S | Indirect | By Aisling Capital II, LP |
Footnotes
- The reportable securities are owned directly by Aisling Capital II, LP ("Aisling"), and held indirectly by Aisling Capital Partners, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling.
Billionaire Hedge Funds
